FDA Inspection
American Red Cross Blood ServicesAmerican Red Cross Blood Services – FDA Inspection, Jul 20, 2026
Record Details
This FDA Inspection record concerns American Red Cross Blood Services, with an inspection on July 20, 2026, issued by the Kansas City District Office, covering biologics.
View Company Profile
ID · 8a6c1d7f-849d-4636-b068-b21d9c2b6f92
Inspection Facts
- Inspection number
- 1327084
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross Blood Services
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 18, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 27, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 27, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Services
- FDA Inspection 1114063 - 2019-12-18
- FDA Inspection 1047337 - 2018-03-27
- FDA Inspection 955257 - 2015-12-10
- FDA Inspection 861062 - 2014-01-03
- FDA Inspection 751561 - 2011-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.